Document:

Form of Severance Agreement

 Exhibit 10.I 
  
 [Date] 
  
 [Officer name] 
 [Address] 
 Dear [Name]: 
  
 On [date], you entered into a letter agreement (the “Agreement”) with Mentor Graphics Corporation (the “Corporation”) regarding compensation and benefits arrangements in connection with a Change in
Control (as defined herein). You and the Corporation now desire to make certain changes to the Agreement. Accordingly, you and the Corporation have agreed to amend and restate the Agreement as follows. 
  
 The Board of Directors (the “Board”) of the Corporation has
determined that it is in the best interests of the Corporation and its shareholders to assure that the Corporation will continue to have your dedication and services notwithstanding the possibility, threat or occurrence of a Change in Control. The
Board believes it is imperative to diminish the distraction that you would face by virtue of the personal uncertainties created by a pending or threatened Change in Control and to encourage your full attention and dedication to the Corporation
currently and in the event of any threatened or pending Change in Control. Further, the Board desires to provide you with compensation and benefits arrangements upon a Change in Control which ensure that your compensation and benefits expectations
will be satisfied and which are competitive with those of other corporations. Therefore, in order to accomplish these objectives, the Board has caused the Corporation to enter into this Agreement. 
  
 1. Term of Agreement. The terms of this Agreement shall become
effective upon the execution hereof by the Corporation and shall continue unless terminated by written agreement between you and the Corporation; provided, that if a Change in Control occurs, then the term of this Agreement shall continue in effect
for a period of not less than [twelve (12)][twenty-four (24)] months beyond the date (the “Change in Control Date”) on which a Change in Control occurs. No benefits shall be payable hereunder unless there has been a Change in Control.

  
 2. Change in Control. A Change in Control shall be
deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events: 
  
 2.1 Acquisition of Stock by Third Party. Any Person (as defined below) is or becomes the Beneficial Owner (as defined below), directly or
indirectly, of securities of the Corporation representing twenty percent (20%) or more of the combined voting power of the Corporation’s then outstanding securities; 
  
 2.2 Change in Board of Directors. During any period of two (2) consecutive years (not including any period prior to
the execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Corporation to effect a transaction
described in Sections 2.1, 2.3 or 2.4) whose election by the Board or nomination for election by the Corporation’s shareholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the
beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the members of the Board; 

 2.3 Corporate Transactions. The effective date of a merger, consolidation or share exchange
involving the Corporation (a “Merger”), other than a Merger which would result in the voting securities of the Corporation outstanding immediately prior to such Merger continuing to represent (either by remaining outstanding or by being
converted into voting securities of the surviving entity) more than 51% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such Merger and with the power to elect at least a majority of the
board of directors or other governing body of such surviving entity; 
  
 2.4 Liquidation. The approval by the shareholders of the Corporation of (a) a plan or proposal for the liquidation or dissolution of the Corporation or (b) the sale, lease, exchange or other transfer (in one transaction or a series
of related transactions) by the Corporation of all or substantially all of the Corporation’s assets; or 
  
 2.5 Other Events. There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of
Regulation 14A (or a response to any similar or successor item on any similar or successor schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Corporation is then subject to such reporting requirement.

  
 2.6 Certain Definitions. For purposes of this Section
2, the following terms shall have the following meanings: 
  
 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. 
  
 “Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act; provided, however, that Person shall exclude (i) the Corporation, (ii) any trustee or other fiduciary holding
securities under an employee benefit plan of the Corporation and (iii) any corporation owned, directly or indirectly, by the shareholders of the Corporation in substantially the same proportions as their ownership of stock of the Corporation.

  
 “Beneficial Owner” shall have the meaning given to
such term in Rule 13d-3 under the Exchange Act; provided, however, that Beneficial Owner shall exclude any Person otherwise becoming a Beneficial Owner by reason of the shareholders of the Corporation approving a Merger. 
  
 3. Termination Following a Change in Control. 
  
 3.1 General. You shall be entitled to the benefits provided in
Section 4 upon (a) the termination of your employment if your employment is terminated after the Change in Control Date or (b) the Change in Control Date if your employment is terminated after the date on which the shareholders of the Corporation
approve a transaction, the consummation of which would result in the occurrence of a Change in Control (the “Approval Date”). 
  

 2 

 3.2 Definition of Disability. If, as a result of your incapacity due to physical or mental
illness, you shall have been absent from the full-time performance of your duties with the Corporation for six (6) consecutive months, and within thirty (30) days after written notice of termination is given you shall not have returned to the
full-time performance of your duties, your employment may be terminated for “Disability.” 
  
 3.3 Definition of Cause. Termination by the Corporation of your employment for “Cause” shall mean termination (a) upon your willful and
continued failure to perform substantially your duties with the Corporation (other than any such failure resulting from your incapacity due to physical or mental illness or any such actual or anticipated failure after your issuance of a Notice of
Termination (as defined in Section 3.5) for Good Reason), after a written demand for substantial performance is delivered to you by the Board which demand specifically identifies the manner in which the Board believes that you have not substantially
performed your duties, (b) upon your willful and continued failure to follow and comply substantially with the specific and lawful directives of the Board, as reasonably determined by the Board (other than any such failure resulting from your
incapacity due to physical or mental illness or any such actual or anticipated failure after your issuance of a Notice of Termination for Good Reason), after a written demand for substantial performance is delivered to you by the Board, which demand
specifically identifies the manner in which the Board believes that you have not substantially followed or complied with the directives of the Board, (c) upon your willful commission of an act of fraud or dishonesty resulting in material economic or
financial injury to the Corporation, or (d) upon your willful engagement in illegal conduct which is materially and demonstrably injurious to the Corporation. For purposes of this Section 3.3, no act, or failure to act, on your part shall be deemed
“willful” unless done, or omitted to be done, by you not in good faith. Notwithstanding the foregoing, you shall not be deemed terminated for Cause pursuant to Sections 3.3(a), (b), (c) or (d) hereof unless and until there shall have been
delivered to you a copy of a resolution duly adopted by the affirmative vote of not less than three-quarters of the entire membership of the Board at a meeting of the Board (after reasonable notice to you, an opportunity for you, together with your
counsel, to be heard before the Board and a reasonable opportunity to cure), finding that in the Board’s good faith opinion you were guilty of conduct set forth above in Section 3.3(a), (b), (c) or (d) and specifying the particulars thereof in
reasonable detail. In the event of a Change in Control under Section 2.3 pursuant to which the Corporation is not the surviving entity, then on and after the Change in Control Date all determinations and actions required to be taken by the Board
under this Section 3.3 shall be made or taken by the board of directors of the surviving entity, or if the surviving entity is a subsidiary, then by the board of directors of the ultimate parent corporation of the surviving entity. 
  
 3.4 Good Reason. You shall be entitled to terminate your employment
for Good Reason. For purposes of this Agreement, “Good Reason” shall mean, without your express written consent, the occurrence after the Approval Date of any of the following circumstances unless, in the case of Sections 3.4(a), (f), (g),
or (h), such circumstances are fully corrected (provided such circumstances are capable of correction) prior to the Date of Termination (as defined in Section 3.6) specified in the Notice of Termination given in respect thereof: 
  
 (a) the assignment to you of any duties inconsistent with the position in
the Corporation that you held immediately prior to the Approval Date, if applicable, or the Change in Control Date, a significant adverse alteration in the nature or status of your responsibilities or the conditions of your employment from those in
effect immediately prior to the Approval Date, if applicable, or the Change in Control Date, or any other action by the Corporation that results in a material diminution in your position, authority, title, duties or responsibilities; 
  

 3 

 (b) the Corporation’s reduction of your annual base salary as in effect on the Approval Date, if
applicable, or the Change in Control Date or as the same may be increased from time to time; 
  
 (c) the relocation of the Corporation’s offices at which you are principally employed immediately prior to the Approval Date, if applicable, or the Change in Control Date (your “Principal Location”) to
a location more than twenty-five (25) miles from such location or the Corporation’s requiring you, without your written consent, to be based anywhere other than your Principal Location, except for required travel on the Corporation’s
business to an extent substantially consistent with your present business travel obligations; 
  
 (d) the Corporation’s failure to pay to you any portion of your current compensation or to pay to you any portion of an installment of deferred compensation under any deferred compensation program of the
Corporation within seven (7) days of the date such compensation is due; 
  
 (e) the Corporation’s failure to continue in effect any material compensation or benefit plan or practice in which you are eligible to participate in on the Approval Date, if applicable, or the Change in Control
Date (other than any equity based plan), unless an equitable arrangement (embodied in an ongoing substitute or alternative plan) has been made with respect to such plan, or the Corporation’s failure to continue your participation therein (or in
such substitute or alternative plan) on a basis not materially less favorable, both in terms of the amount of benefits provided and the level of your participation relative to other participants, as existed at the time of the Approval Date, if
applicable, or the Change in Control Date; 
  
 (f) the
Corporation’s failure to continue to provide you with benefits substantially similar in the aggregate to those enjoyed by you under any of the Corporation’s life insurance, medical, health and accident, disability, pension, retirement, or
other benefit plans or practices in which you and your eligible family members were eligible to participate in on the Approval Date, if applicable, or the Change in Control Date (other than any equity based plans), the taking of any action by the
Corporation which would directly or indirectly materially reduce any of such benefits, or the failure by the Corporation to provide you with the number of paid vacation days to which you are entitled on the basis of years of service with the
Corporation in accordance with the Corporation’s normal vacation policy in effect on the Approval Date, if applicable, or the Change in Control Date; 
  
 (g) the Corporation’s failure to obtain a satisfactory agreement from any successor to assume and agree to perform this Agreement, as contemplated
in Section 6 hereof; or 
  

 4 

 (h) any purported termination of your employment that is not effected pursuant to a Notice of
Termination satisfying the requirements of Section 3.6 hereof (and, if applicable, the requirements of Section 3.3 hereof), which purported termination shall not be effective for purposes of this Agreement. 
  
 Your right to terminate your employment pursuant to this Section 3.4 shall
not be affected by your incapacity due to physical or mental illness. Your continued employment shall not constitute consent to, or a waiver of rights with respect to, any circumstance constituting Good Reason hereunder. 
  
 3.5 Notice of Termination. Any purported termination of your
employment by the Corporation or by you (other than termination due to death which shall terminate your employment automatically) shall be communicated by written Notice of Termination to the other party hereto in accordance with Section 7.
“Notice of Termination” shall mean a notice that shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for
termination of your employment under the provision so indicated. 
  
 3.6 Date of Termination, Etc. “Date of Termination” shall mean (a) if your employment is terminated due to your death, the date of your death; (b) if your employment is terminated for Disability, thirty (30) days after
Notice of Termination is given (provided that you shall not have returned to the full-time performance of your duties during such thirty (30) day period), and (c) if your employment is terminated pursuant to Section 3.3 or Section 3.4 or for any
other reason (other than death or Disability), the date specified in the Notice of Termination (which, in the case of a termination for Cause shall not be less than thirty (30) days from the date such Notice of Termination is given, and in the case
of a termination for Good Reason shall not be less than fifteen (15) nor more than sixty (60) days from the date such Notice of Termination is given). Notwithstanding anything to the contrary contained in this Section 3.6, if within fifteen (15)
days after any Notice of Termination is given, the party receiving such Notice of Termination notifies the other party that a dispute exists concerning the termination, then the Date of Termination shall be the date on which the dispute is finally
determined, either by mutual written agreement of the parties, or otherwise; provided, however, that (i) the Date of Termination shall be extended by a notice of dispute only if such notice is given in good faith and the party giving such notice
pursues the resolution of such dispute with reasonable diligence; and (ii) in the event of your death pending a dispute, and the resolution of such dispute is ultimately in your favor, then the Date of Termination shall be the date specified in the
Notice of Termination. 
  
 4. Compensation Upon Termination.
The benefits to which you are entitled upon termination of your employment, subject to Section 3 and the other terms and conditions of this Agreement, are: 
  

4.1 Cause or Voluntary Termination. If your employment shall be terminated by the Corporation for Cause or voluntarily terminated by you other
than for Good Reason, the Corporation shall pay you your full base salary through the Date of Termination at the rate in effect at the time Notice of Termination is given, plus all other amounts to which you are entitled under any compensation plan
or practice of the Corporation, and the Corporation shall have no further obligations to you under this Agreement. 
  

 5 

 4.2 Good Reason or Termination By Corporation Without Cause. If your employment by the Corporation
shall be terminated by you for Good Reason, or by the Corporation other than for Cause, Disability or death, then you shall be entitled to the benefits provided below: 
  
 (a) the Corporation shall pay to you your full base salary, when due, through the Date of Termination at the rate in effect
at the time Notice of Termination is given, at the time specified in Section 4.3, plus (i) that portion of your targeted cash bonuses prorated through the Date of Termination, (ii) all accrued but unused vacation time through the Date of Termination
and (iii) all other amounts to which you are entitled under any compensation plan or practice of the Corporation at the time such payments are due; 
  
 (b) in lieu of any further salary payments to you for periods subsequent to the Date of Termination, the Corporation shall pay as severance pay to you,
at the time specified in Section 4.3, a lump sum payment equal to the sum of the following: 
  
 (1) [one and one-half (1.5)][three (3)] times your annual base salary as in effect at the time the Notice of Termination is given or immediately prior to the Change in Control Date (or the Approval Date if the Date of
Termination is prior to the Change in Control Date), whichever is greater; and 
  
 (2) [one and one-half (1.5)][three (3)] times your targeted annual bonus as in effect at the time the Notice of Termination is given or immediately prior to the Change in Control Date (or the Approval Date if the Date
of Termination is prior to the Change in Control Date), whichever is greater; and 
  
 (c) for a period of two (2) years following the Date of Termination, the Corporation shall, at its sole expense as incurred, provide you with outplacement services, the scope and provider of which shall be consistent
with your status at the Corporation on the Date of Termination; 
  
 (d) for a[n] [eighteen (18)][thirty-six (36)] month period after such termination, the Corporation shall continue to provide you and your eligible family members, based on the cost sharing arrangement between you and the Corporation at the
time the Notice of Termination is given, with medical and dental health benefits and life and disability benefits at least equal to those which would have been provided to you and them if your employment had not been terminated or, if more favorable
to you, as in effect generally at any time thereafter; provided, however, that if you become re-employed with another employer and are eligible to receive such benefits under another employer’s plans, the Corporation’s obligations under
this Section 4.2(d) shall be reduced to the extent comparable benefits are actually received by you during the [eighteen (18)][thirty-six (36)] month period following your termination, and any such benefits actually received by you shall be reported
to the Corporation. In the event you are ineligible under the terms of such benefit plans or programs to continue to be so covered, the Corporation shall provide you with substantially equivalent coverage through other sources or 

  

 6 

 
will provide you with a lump-sum payment in such amount that, after all taxes on that amount, shall be equal to the cost to you of providing yourself such
benefit coverage. At the termination of the medical and dental benefits coverage under the second preceding sentence, you, your spouse and your dependents shall be entitled to continuation coverage pursuant to section 4980B of the Internal Revenue
Code of 1986, as amended (the “Code”), sections 601-608 of the Employee Retirement Income Security Act of 1974, as amended, and under any other applicable law, to the extent required by such laws, as if you had terminated employment with
the Corporation on the date such benefits coverage terminates. The lump-sum shall be determined on a present value basis using the interest rate provided in section 1274(b)(2)(B) of the Code on the Date of Termination; 
  
 (e) the Corporation shall furnish you for six (6) years following the Date
of Termination (without reference to whether the term of this Agreement continues in effect) with directors’ and officers’ liability insurance insuring you against insurable events which occur or have occurred while you were a director or
officer of the Corporation, such insurance to have policy limits aggregating not less than the amount in effect immediately prior to the Change in Control or the Approval Date (whichever is more favorable to you), and otherwise to be in
substantially the same form and to contain substantially the same terms, conditions and exceptions as the liability issuance policies provided for officers and directors of the Corporation in force from time to time, provided, however, that (i) such
terms, conditions and exceptions shall not be, in the aggregate, materially less favorable to you than those in effect on the date hereof and (ii) if the aggregate annual premiums for such insurance at any time during such period exceed two hundred
percent (200%) of the per annum rate of premium currently paid by the Corporation for such insurance, then the Corporation shall provide the maximum coverage that will then be available at an annual premium equal to two hundred percent (200%) of
such rate; 
  
 (f) you shall be fully vested in your accrued
benefits under all qualified or nonqualified pension, profit sharing, deferred compensation or supplemental plans maintained by the Corporation for your benefit, and the Corporation shall provide you with additional fully vested benefits under all
defined benefit and cash balance plans in an amount equal to the benefits which you would have accrued had you continued your employment with the Corporation until the second anniversary of your Date of Termination; provided, however, that to the
extent that the acceleration of vesting or enhanced accrual of such benefits would violate any applicable law or require the Corporation to accelerate the vesting of the accrued benefits of all participants in such plan or plans or to provide
additional benefit accruals to such participants, the Corporation shall pay you a lump-sum payment at the time specified in Section 4.3 in an amount equal to the value of such benefits; 
  
 (g) in the event you relocate during the period of [twelve (12)][thirty-six (36)] months following the Date of Termination
in order to begin new employment, your costs (grossed up for taxes) of such relocation shall be provided by the Corporation as if the Corporation had (i) hired you as of the date of this Agreement and provided you with its “B+” relocation
package or (ii) hired you on the Date of Termination, whichever is greater; and (h) all unvested stock options held by you on the Date of Termination shall immediately vest and become exercisable in full and shall remain exercisable for the period
specified in such options, notwithstanding any vesting schedule or other provisions to the contrary in the agreements or plans evidencing such options. 
  

 7 

 4.3 Timing of Payments under Sections 4.1 and 4.2. The payments provided for in (a) Section 4.1
and (b) Sections 4.2(a), (b) and (f) shall be made not later than the fifth day following the Date of Termination (or, if the Date of Termination occurs after the Approval Date but before the Change in Control Date, the fifth day following the
Change in Control Date); provided, however, that if the amounts of such payments cannot be finally determined on or before such day, the Corporation shall pay to you on such day an estimate, as determined in good faith by the Corporation, of the
minimum amount of such payments and shall pay the remainder of such payments (together with interest at the rate provided in section 1274(b)(2)(B) of the Code) from the Date of Termination as soon as the amount thereof can be determined but in no
event later than the thirtieth day after the Date of Termination or the Change in Control Date, as applicable. In the event that the amount of the estimated payments exceeds the amount subsequently determined to have been due, such excess shall
constitute a loan by the Corporation to you, payable on the fifth day after demand by the Corporation (together with interest at the rate provided in section 274(b)(2)(B) of the Code) from the date such payment was made by the Corporation.

  
 4.4 Death or Disability. If your employment by the
Corporation shall be terminated by reason of death or Disability, the Corporation shall continue payment of your annual base salary, at the rate then in effect on the date of such termination, for a period of one year. 
  
 4.5 No Mitigation. You shall not be required to mitigate the amount of
any payment provided for in this Section 4 by seeking other employment or otherwise nor, except as provided in Section 4.2(d), shall the amount of any payment or benefit provided for in this Section 4 be reduced by any compensation earned by you as
the result of employment by another employer or self-employment, by retirement benefits, by offset against any amount claimed to be owed by you to the Corporation, or otherwise. 
  
 5. Taxes. You shall bear all expense of, and be solely responsible for, all federal, state, local or foreign taxes
due with respect to any payment received hereunder, including, without limitation, any excise tax imposed by Section 4999 of the Code; provided, however, that any payment or benefit received or to be received by you in connection with a Change in
Control or the termination of your employment (whether payable pursuant to the terms of this Agreement (“Contract Payments”) or any other plan, arrangements or agreement with the Corporation or an affiliate (collectively with the Contract
Payments, the “Total Payments”)) that would constitute a “parachute payment” within the meaning of Section 280G of the Code, shall be reduced to the extent necessary so that no portion thereof shall be subject to the excise tax
imposed by Section 4999 of the Code but only if, by reason of such reduction, the net after-tax benefit received by you shall exceed the net after-tax benefit received by you if no such reduction was made. For purposes of this Section 5, “net
after-tax benefit” shall mean (i) the Total Payments which you receive or are then entitled to receive from the Corporation that would constitute “parachute payments” within the meaning of Section 280G of the Code, less (ii) the
amount of all federal, state and local income and employment taxes payable by you with respect to the foregoing calculated at the highest marginal income tax rate for each year in which the foregoing shall be 

  

 8 

 
paid to you (based on the rate in effect for such year as set forth in the Code as in effect at the time of the first payment of the foregoing), less (iii)
the amount of excise taxes imposed with respect to the payments and benefits described in (i) above by Section 4999 of the Code. The foregoing determination will be made by the Corporation’s independent certified public accountants serving
immediately prior to the Change in Control (the “Accountants”). In the event that the Accountants are also serving as accountant or auditor for the individual, group or entity effecting the Change in Control you may appoint another
nationally recognized public accounting firm to make the determination required hereunder (which firm shall then be referred to as the Accountants hereunder). All fees and expenses of the Accountants shall be borne by the Corporation. You will
direct the Accountants to submit their determination and detailed supporting calculations to both you and the Corporation within fifteen (15) days of receipt from you or the Corporation that you have received or will receive the Total Payments. If
the Accountants determine that such reduction is required by this Section 5, you, in your sole and absolute discretion, may determine which Total Payments shall be reduced to the extent necessary so that no portion thereof shall be subject to the
excise tax imposed by Section 4999 of the Code, and the Corporation shall pay such reduced amount to you. You and the Corporation will each provide the Accountants access to and copies of any books, records, and documents in the possession of you or
the Corporation, as the case may be, reasonably requested by the Accountants, and otherwise cooperate with the Accountants in connection with the preparation and issuance of the determinations and calculations contemplated by this Section 5.

  
 6. Successors; Binding Agreement. 
  
 6.1 Successor to Assume Agreement. The Corporation shall require any
successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Corporation to expressly assume and agree to perform this Agreement. Failure of the Corporation
to obtain such assumption and agreement prior to the Change in Control Date shall be a breach of this Agreement and shall entitle you to terminate your employment and receive compensation from the Corporation in the same amount and on the same terms
to which you would be entitled hereunder if you terminate your employment for Good Reason following the Approval Date or, if inapplicable, the Change in Control Date, except that for purposes of implementing the foregoing, the Change in Control Date
shall be deemed the Date of Termination. Unless expressly provided otherwise, “Corporation” as used herein shall mean the Corporation as defined in this Agreement and any successor to its business and/or assets as aforesaid. 
  
 6.2 Binding Agreement. This Agreement shall inure to the benefit of
and be enforceable by you and your personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If you should die while any amount would still be payable to you hereunder had you continued to
live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to your devisee, legatee or other designee or, if there is no such designee, to your estate. 
  
 7. Notice. All notices, requests, demands and other communications
which are required or may be given under this Agreement shall be in writing and shall be deemed to have been duly given when received if personally delivered; when transmitted if transmitted by telecopy; the day after it is sent, if sent for next
day delivery to a domestic address by recognized 

  

 9 

 
overnight delivery service (e.g., FedEx); and upon receipt, if sent by certified or registered mail, return receipt requested. All notices, requests, demands
and other communications shall be addressed to the respective addresses set forth on the first page of this Agreement, provided that all notices to the Corporation shall be directed to the attention of the Board with a copy to the Secretary of the
Corporation, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon receipt. 
  
 8. Miscellaneous. No provision of this Agreement may be modified,
waived or discharged unless such waiver, modification or discharge is agreed to in writing and signed by you and such officer as may be specifically designated by the Board. No waiver by either party hereto at any time of any breach by the other
party hereto of or compliance with, any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. No
agreements or representations, oral or otherwise, express or implied, with respect to the subject matter hereof have been made by either party which are not expressly set forth in this Agreement. All references to sections of the Exchange Act or the
Code shall be deemed also to refer to any successor provisions to such sections. Any payments provided for hereunder shall be paid net of any applicable withholding required under federal, state or local law. The obligations of the Corporation under
Section 4 shall survive the expiration of the term of this Agreement. The section headings contained in this Agreement are for convenience only, and shall not affect the interpretation of this Agreement. 
  
 9. Severability. The invalidity or unenforceability of any provision
of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 
  
 10. Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all of which together
shall constitute one and the same instrument. 
  
 11.
Suits, Actions, Proceedings, Etc. 
  
 11.1 Compensation
During Dispute, Etc. Your compensation during any disagreement, dispute, controversy, claim, suit, action or proceeding (collectively, a “Dispute”), arising out of or relating to this Agreement or the interpretation of this Agreement
shall be as follows: If there is a termination followed by a Dispute as to whether you are entitled to the payments and other benefits provided under this Agreement, then, during the period of that Dispute the Corporation shall pay you fifty percent
(50%) of the amount specified in Sections 4.2(a) and 4.2(b) hereof, and the Corporation shall provide you with the other benefits provided in Section 4.2 of this Agreement, if, but only if, you agree in writing that if the Dispute is resolved
against you, you shall promptly refund to the Corporation all payments you receive under Sections 4.2(a) and 4.2(b) of this Agreement plus interest at the rate provided in Section 1274(d) of the Code, compounded quarterly. If the Dispute is resolved
in your favor, promptly after resolution of the dispute the Corporation shall pay you the sum that was withheld during the period of the Dispute plus interest at the rate provided in Section 1274(d) of the Code, compounded quarterly. 
  

 10 

 11.2 Legal Fees. The Corporation shall pay to you all legal fees and expenses incurred by you in
connection with any Dispute arising out of or relating to this Agreement or the interpretation thereof in which you are the prevailing party (including, without limitation, all such fees and expenses, if any, incurred in contesting or disputing any
termination of your employment or in seeking to obtain or enforce any right or benefit provided by this Agreement, or in connection with any tax audit or proceeding to the extent attributable to the application of section 4999 of the Code to any
payment or benefit provided hereunder). 
  
 11.3 Choice of Law;
Arbitration. The internal laws of the State of Oregon, United States of America, applicable to contracts entered into and wholly to be performed in Oregon by Oregon residents, without reference to any principles concerning conflicts of law,
shall govern the validity of this Agreement, the construction of its terms and the interpretation of the rights and duties of the parties hereunder; provided, however, that this Section 11.3 and the parties’ rights under this Section 11.3 shall
be governed by and construed in accordance with the Federal Arbitration Act, 9 U.S.C. ss. 1 et. sec. Any controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall be settled by the following procedures: Either
party may send the other written notice identifying the matter in dispute and involving the procedures of this Section 11.3. Within fourteen (14) days after such written notice is given, one or more principals of each party shall meet at a mutually
agreeable location in Portland, Oregon, for the purpose of determining whether they can resolve the dispute themselves by written agreement, and, if not, whether they can agree upon a third-party impartial arbitrator (the “Arbitrator”) to
whom to submit the matter in dispute for final and binding arbitration. If the parties fail to resolve the dispute by written agreement or agree on the Arbitrator within such twenty-one (21) day period, either party may make written application to
the Judicial Arbitration and Mediation Services (“JAMS”), 600 University Street, Suite 1910, Seattle, Washington 98101, for the appointment of a single Arbitrator to resolve the dispute by arbitration and at the request of JAMS, the
parties shall meet with JAMS at its offices or confer with JAMS by telephone within ten (10) calendar days of such request to discuss the dispute and the qualifications and experience which each party respectively believes the Arbitrator should
have; provided, however, the selection of the Arbitrator shall be the exclusive decision of JAMS and shall be made within thirty (30) days of the written application to JAMS. Within 30 days of the selection of the Arbitrator, the parties shall meet
in Portland, Oregon with such Arbitrator at a place and time designated by the Arbitrator after consultation with the parties and present their respective positions on the dispute. Each party shall have no longer than one day to present its
position, the entire proceedings before the Arbitrator shall be on no more than three consecutive days, and the award shall be made in writing no more than 30 days following the end of the proceeding. Such award shall be a final and binding
determination of the dispute and shall be fully enforceable as an arbitration award in any court having jurisdiction and venue over the parties. The prevailing party (as determined by the Arbitrator) shall in addition be awarded by the Arbitrator
such party’s own attorneys’ fees and expenses in connection with such proceeding. The non-prevailing party (as determined by the Arbitrator) shall pay the Arbitrator’s fees and expenses. 
  
 12. Effect on Other Agreements. In the event that you are a party to
any employment agreement (“Employment Agreement”) with the Corporation, it is the intention that this Agreement provide benefits which are not otherwise provided by any Employment Agreement. Therefore, in the event that during the term of
this Agreement you are entitled to 

  

 11 

 
payment under both this Agreement and any Employment Agreement, then you shall only receive the greater of the benefits provided under either this Agreement
or such Employment Agreement, but not both. In the event you receive benefits under this Agreement, you waive all rights to receive any benefits under such Employment Agreement, and vice versa. 
  
 13. Entire Agreement. This Agreement sets forth the entire agreement
of the parties hereto in respect of the subject matter contained herein and supersedes all other prior agreements, promises, covenants, arrangements, communications, representations or warranties, whether oral or written, by any officer, employee or
representative of any party hereto; and any prior agreement of the parties hereto in respect of the subject matter contained herein, including, without limitation, any prior severance agreements, is hereby terminated and canceled; provided, however,
that any Employment Agreement as amended by Section 12 hereof shall remain in full force and effect and shall, pursuant to the terms and conditions thereof, provide certain severance benefits to you upon certain terminations of employment. Subject
to Section 12 of this Agreement, any of your rights hereunder shall be in addition to any rights you may otherwise have under benefit plans or agreements of the Corporation to which you are a party or in which you are a participant, including, but
not limited to, any Corporation sponsored employee benefit plans and stock options plans. Subject to Section 12 of this Agreement, provisions of this Agreement shall not in any way abrogate your rights under such other plans and agreements.

  
 If this letter sets forth our agreement on the subject matter
hereof, kindly sign and return to the Corporation the enclosed copy of this letter. A duly authorized officer of the Corporation will sign this letter and a fully executed copy will be returned to you, constituting our agreement on this subject.
Unless and until accepted in writing by the Corporation, this Agreement is deemed to be neither executed nor effective. 
  

			
	Sincerely,
	
	MENTOR GRAPHICS CORPORATION
		
	By:	 	  

	Its:	 	  

  

	
	Agreed and Accepted,
	 this          day of
                    , 200    .

	  

	 [Officer signature]

  

 12Wilk License Agreement Dated January 13, 2005

 EXHIBIT 10.14 
  
 SETTLEMENT AND LICENSE AGREEMENT 
  
 This Settlement and License Agreement (“Agreement”) is entered into by and between on the one hand Brookhill-Wilk
1, LLC, a New York corporation having a principal place of business at 501 Madison Avenue, New York, NY 10022 (“Brookhill-Wilk”), Wilk Patent Development Corporation, a New York corporation having a principal place of business at 475 East
72nd Street, Suite L1, New York, NY 10021 (referred to as “WPDC”), and Peter J. Wilk, an individual (“Wilk” and collectively with Brookhill-Wilk and WPDC, “Licensors”), and on the other hand Intuitive Surgical, Inc., a
Delaware corporation, having a principal place of business at 950 Kifer Road, Sunnyvale, CA 94086. Brookhill-Wilk, WPDC, Licensors, and Intuitive Surgical, Inc. may be referred to singly and jointly as “Party,” or “Parties,”
respectively. 
  
 WHEREAS, Brookhill-Wilk claims to have exclusive
licenses to and the exclusive right to protect and enforce and to bring any legal and equitable actions based on United States Patent Nos. 5,217,003 (the “003 Patent”), and 5,368,015 (the “015 Patent”) both entitled
“Automated Surgical System and Apparatus,” (collectively, the “Brookhill-Wilk Patents”); 
  
 WHEREAS, Wilk is a joint owner as co-inventor of U.S. Patent No. 5,776,126, entitled “Laparoscopic Surgical Apparatus and Associated Method”
(“the “126 Patent”); 
  
 WHEREAS, Wilk claims to
own the entire right, title and interest in U.S. Patent No. 5,217,453, entitled “Automated Surgical System and Apparatus” and additional issued United States patents and patent applications and issued foreign patents and patent
applications on which Wilk is named as a sole or co-inventor and/or which are assigned to entities owned in whole or part by Wilk, and which relate to surgical robotic systems, procedures, products, accessories, and methods for their use that may be
alleged to have been, currently be, or may in the future be practiced by Intuitive (as the term “Intuitive” is specifically defined below) (collectively, the “Wilk Patents”); 
  
 WHEREAS, Brookhill-Wilk brought in the United States District Court for the
Southern District of New York, a civil action asserting infringement by Intuitive Surgical, Inc. of the ‘003 and ‘015 Patents entitled Brookhill Wilk 1, LLC v. Intuitive Surgical, Inc., Civil Action No. 00-CV-6599; 
  
 WHEREAS, Brookhill-Wilk brought in the United States District Court for the
Southern District of New York, a civil action asserting infringement by Computer Motion, Inc. (“CMI”) of the ‘003 and ‘015 Patents entitled Brookhill Wilk 1, LLC v. Computer Motion, Inc., Civil Action No. 0l-CV-1300, which
action was dismissed without prejudice; 
  
 WHEREAS,
Brookhill-Wilk brought in the United States District Court for the Southern District of New York, a civil action asserting infringement by Intuitive Surgical, Inc.’s customers of the ‘003 Patent entitled Brookhill Wilk 1, LLC v. The
Mount Sinai Hospital, New York Presbyterian Healthcare System, Inc., and Lenox Hill Hospital, Civil Action No. 03-CV-4977; 
  
 WHEREAS, on or about June 30, 2003, Intuitive Surgical, Inc. and CMI entered into a merger agreement under which CMI became a wholly owned subsidiary of
Intuitive Surgical, Inc.; 
  
 WHEREAS, Brookhill-Wilk, on remand
of its suit against Intuitive Surgical, Inc. by the United States Court of Appeals for the Federal Circuit amended its complaint against Intuitive Surgical, Inc. to assert in addition to its claims against Intuitive Surgical, Inc., the claims it had
previously brought against CMI in Civil Action No, 0l-CV-1300 in a lawsuit entitled Brookhill Wilk 1, LLC v. Intuitive Surgical, Inc. and Computer Motion, Inc., Civil Action No, 00-CV-6599; 
  
 WHEREAS, on the terms and conditions set forth below, Brookhill-Wilk and
Intuitive Surgical, Inc. want to resolve all pending litigation between the Parties, and between Brookhill-Wilk and Intuitive Surgical, Inc.’s 

  

 1 

 
customers, and seek an amicable and final business resolution and settlement of other possible claims relating to the past, present, and future use,
manufacture, offer for sale, sale and importation of surgical robotic systems, procedures, methods, products, and accessories by or on behalf of Intuitive Surgical, Inc., CMI, and their subsidiaries and customers which claims were, could have been,
or can in the future be asserted by Licensors; 
  
 WHEREAS,
Licensors represent that this Agreement is dispositive of all infringement claims that were or that could have been brought by Licensors against Intuitive Surgical, Inc., CMI, their subsidiaries and its (and their) respective direct and indirect
customers, other transferees, manufacturers, distributors and resellers related to their alleged infringement of the ‘003 and ‘015 Patents; 
  
 WHEREAS, Licensors represent that this Agreement is dispositive of all infringement claims that can be brought by Licensors against Intuitive Surgical,
Inc., CMI, their subsidiaries and its (and their) respective direct and indirect customers, other transferees, manufacturers, distributors and resellers relating to any claim of infringement by them of the Wilk Patents; 
  
 NOW, THEREFORE, in accordance with the above recitals and in consideration of
the mutual covenants contained in this Agreement, Licensors and Intuitive Surgical, Inc. agree as follows: 
  
 SECTION 1 
 DEFINITIONS 
  
 As used in this Agreement, the following terms shall be deemed to have the
following meanings: 
  
 1.1 “Effective Date” shall mean
January 13, 2004. 
  
 1.2 “Intuitive” shall mean
Intuitive Surgical, Inc., any of its subsidiaries, and its (and their) respective direct and indirect customers and users of its products, other transferees, manufacturers, distributors and resellers of the Licensed Products, and each of their
officers, directors, employees, stockholders, cooperative members, affiliates, subsidiaries, predecessors, successors and successors in interest, and assigns. 
  

1.3 “Licensed Patents” shall mean the Brookhill-Wilk Patents, the ‘126 Patent, and the Wilk Patents and each issued patent and all
patent applications pending as of the Effective Date related thereto, including: 
  
 1.3.1 reissued and reexamined patents and their applications, 
  
 1.3.2 divisional, continuation and continuation-in-part applications, 
  
 1.3.3 each patent issuing from each of said applications,
and 
  
 1.3.4 the foreign counterparts of each of
said patents and applications. 
  
 1.3.5 Licensed
Patents does not include any patent or patent applications that are filed after the Effective Date except as to those identified in Paragraphs 1.3.1. 1.3.2, 1.3.3, and 1.3.4 of this Agreement. 
  
 1.4 “Licensed Product,” singular or plural, shall mean any surgical
robotic system, procedure, product, or accessory made by or for Intuitive and/or the method by which any or all are used, where the use, offer for sale, sale, manufacture, importation or other disposition of such procedure, product, or accessory
would, whether directly or indirectly (e.g., through contribution or inducement), constitute an infringement of any claim of the Licensed Patents, but for the rights and licenses granted in this Agreement. 
  
 SECTION 2 
 SETTLEMENT UNDERSTANDING 
  
 The Parties understand and agree that this Agreement, any consideration given or accepted in connection with it, and the covenants made in it are all made, given and accepted in settlement and compromise of disputed
claims. 
  

 2 

 SECTION 3 
 GRANT OF LICENSES, COVENANTS AND RELEASE 
  
 3.1 Subject only to the timely payment by Intuitive of the one-time license fee referenced in Section 4 (“LICENSE FEE, TERMINATION”) of this Agreement, Brookhill-Wilk hereby grants to Intuitive, under the
Brookhill-Wilk Patents, a perpetual, exclusive, fully paid-up, royalty-free transferable, license to use, supply, make (and have made), sell, offer to sell, import, and export any surgical robotic system, product, or accessory and to practice any
methods and procedures with those systems, products, and accessories, and to otherwise practice any of the Brookhill-Wilk Patent rights as Intuitive sees fit in its sole discretion without limitation as to field. 
  
 3.2 Subject only to the timely payment by Intuitive of the one-time license
fee referenced in Section 4 (“LICENSE FEE, TERMINATION”) of this Agreement, Wilk and WPDC on behalf of themselves and their successors, hereby grant to Intuitive a perpetual, fully paid-up, royalty-free covenant not to sue Intuitive on the
Wilk Patents. This covenant not to sue applies to past, current and future Licensed Products. 
  
 3.3 Subject only to the timely payment by Intuitive of the one-time license fee referenced in Section 4 (“LICENSE FEE, TERMINATION”) of this Agreement, Wilk and WPDC hereby grant to Intuitive, a perpetual,
fully paid-up, royalty-free non-exclusive license on the ‘126 Patent to use, supply, make (and have made), sell, offer to sell, import, and export any surgical robotic system, product, or accessory and to practice any methods and procedures
with those systems, products, and accessories, and to otherwise practice the ‘126 Patent rights as Intuitive sees fit in its sole discretion without limitation as to field. 
  
 3.4 Subject only to the timely payment by Intuitive of the one-time license fee referenced in Section 4 (“LICENSE FEE,
TERMINATION”) of this Agreement, Intuitive, Brookhill-Wilk, Wilk and WPDC agree that they shall within five (5) business days after the Effective Date: 
  
 3.4.1 dismiss with prejudice all claims, demands, and causes of action that Licensors have asserted or could have asserted against
Intuitive and/or Computer Motion, Inc. in Civil Action No. 00-CV-6599. Concurrently with said dismissal by Brookhill-Wilk, Intuitive shall also dismiss with prejudice all counterclaims, demands and causes of actions it asserted or could have
asserted against Brookhill-Wilk, Wilk and WPDC in Civil Action Nos. 00-CV-6599; 
  
 3.4.2 dismiss with prejudice all claims, demands, and causes of action that Licensors have asserted or could have asserted against The
Mount Sinai Hospital, New York Presbyterian Healthcare System, Inc., and Lenox Hill Hospital in Civil Action No. 03-CV-4977. 
  
 3.4.3 Intuitive and Licensors, for themselves and for each of their subsidiaries, related companies, predecessors, successors, heirs,
assigns, and agents irrevocably release and forever discharge each other from and for any and all claims, causes of action, suits, damages, demands, duties, rights, obligations, liabilities, adjustments, responsibilities, judgments, trespasses and
liabilities of any nature whatsoever, at law or in equity, whether asserted or unasserted, whether known or unknown, whether suspected or unsuspected to exist, and Licensors further covenant not to sue Intuitive directly or indirectly based on
activities, that relate in any way to any of the Licensed Patents or any claims which were, could have been, or could be brought or made in any lawsuit relating to infringement of any of the Licensed Patents which it has the rights to; 

 
 3.5 LICENSORS RECOGNIZE THAT A GENERAL RELEASE MAY NOT EXTEND TO CLAIMS
WHICH THE LICENSORS DO NOT KNOW OR SUSPECT TO EXIST IN HIS OR THEIR FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY ANY OR ALL OF THE LICENSORS WOULD HAVE MATERIALLY AFFECTED HIS OR THEIR ENTRY INTO THIS AGREEMENT WITH INTUITIVE. IN
GRANTING THE LICENSES AND COVENANTS CONTAINED IN THIS AGREEMENT, LICENSORS EXPRESSLY INTEND THAT THIS AGREEMENT SHALL INCLUDE ALL CLAIMS 

  

 3 

 
KNOWN, UNKNOWN, AND UNSUSPECTED, AND LICENSORS EXPRESSLY WAIVE THEIR RIGHTS UNDER ANY APPLICABLE STATUTE REGARDING THE UNENFORCEABILITY OF GENERAL RELEASES.

  
 SECTION 4 
 LICENSE FEE, TERMINATION 
  
 4.1 In full consideration of the value received under this Agreement from Licensors, Intuitive agrees to pay a one-time license fee in the amount of Two
Million Six Hundred Thousand U.S. Dollars ($2,600,000.00). This license fee is non-refundable. Payment of this license fee shall be made within five (5) business days of the Effective Date. 
  
 4.2 The $2,600,000.00 license fee shall be paid as follows, via wire-transfer
from Intuitive to the following accounts: 
  
 4.2.1 Recipient’s name: Wilk Patent Development Corp. 
 Recipient’s address: 475 East 72nd Street, New York, NY 10021 
 Bank name: Citibank N.A. 
 Address: 162 Amsterdam Avenue, New York, NY 10021 
 Recipient’s account number: 47589078 
 Routing number: 021000089 
 Amount: $1,075,000.00 
  
 4.2.2 Recipient’s name: Brookhill Management Corp.

 Bank name: United States Trust Co. of NY 
 Bank address: 11 West 54th Street, New York, NY 10019 
 Recipient’s account number: 20-2602-3 
 ABA#: 021001318 
 Amount: $1,525,000.00 
  
 4.3 Upon payment of the
one-time license fee of Section 4.1 in accordance with the payment instructions of Section 4.2, this Agreement, the payment, and the license grants and releases contained in it become non-terminable and non-revocable. 
  
 SECTION 5 
 TERM 
  
 5.1 The rights, licenses and covenants not to sue or assert and the releases granted under this Agreement shall commence on the Effective Date. 
  
 5.2 This Agreement shall remain in full force and effect during the pendency and life of, and until the expiration of the last to expire of, the Licensed
Patents. 
  
 5.3 All rights and licenses granted under or pursuant
to this Agreement by Licensors to Intuitive are, and shall otherwise be deemed to be, for purposes of Section 365(n) of Title 11, U.S. Code (the “Bankruptcy Code”), licenses and rights to “intellectual property” as defined under
Section 101 of the Bankruptcy Code. The Parties agree that Intuitive, as licensee of such rights under this Agreement, shall retain and may fully exercise all of its rights and elections under the Bankruptcy Code. 
  
 SECTION 6 
 NOTICE 
  
 6.1 Any notice required or permitted to be given under this Agreement shall be given to each other Party in writing and delivered by overnight courier, signature of receipt required, and shall be deemed delivered upon 

  

 4 

 
written confirmation of delivery by the courier, if sent to the following respective addresses or such new addresses as may from time to time be supplied by
the Parties. 
  

			
	To Brookhill-Wilk, LLC:	  	 Brookhill-Wilk, LLC
 501 Madison Avenue,
 New York, NY 10022
 Attention: Ronald B. Bruder

		
	 With a copy to:
	  	 Levisohn, Berger & Langsam, LLP
 805 Third Avenue,
19th Floor
 New York,
New York 10022
 Attention: Peter L. Berger
 Telephone: (212)
486-7272
 Facsimile: (212) 486-0323

		
	 To Peter J. Wilk:
	  	 475 East 72nd
Street, Suite L1
 New York, NY 10021
 Telephone: (212)
744-5122
 Facsimile: (212) 982-3202

		
	 With a copy to:
	  	 Donald G. Leka, Esq.
 140 Sewall Avenue
 Brookline, MA 02446
 Telephone: (617) 359-3664
 Facsimile: (617) 734-0745

		
	 To Wilk Patent Development Corp.
	  	 475 East 72nd
Street, Suite L1
 New York, NY 10021
 Attention: Peter J.
Wilk
 Telephone: (212) 744-5122
 Facsimile: (212)
982-3202

		
	 With a copy to:
	  	 Sol V. Slotnik, Esq.
 11 East 44th Street, 17th Floor
 New York, New York 10017
 Telephone: (212) 687-1222
 Facsimile: (212) 986-2399

		
	 With a copy to:
	  	 Donald G. Leka, Esq.
 140 Sewall Avenue
 Brookline, MA 02446
 Telephone: (617) 359-3664
 Facsimile: (617) 734-0745

		
	 To Intuitive:
	  	 Intuitive Surgical, Inc.
 950 Kifer Road
 Sunnyvale, CA 94086
 Attention: Lonnie Smith
 Telephone: (408) 523-2100
 Facsimile: (408) 5231390

		
	 With a copy to:
	  	 Fish & Richardson, P.C.
 500 Arguello Street,
Suite 500
 Redwood City, CA 94063
 Attention: David M.
Barkan
 Telephone: (650) 839-5070
 Facsimile: (650)
839-5071

  

 5 

 SECTION 7 
 WARRANTIES AND INDEMNIFICATION 
  
 7.1 Brookhill-Wilk represents and warrants that: 
  
 7.1.1 it is a company in good standing under the laws of the State of New York; 
  
 7.1.2 it has the authority to enter into this Agreement; 
  
 7.1.3 this Agreement is valid, binding and enforceable in accordance with its terms; 
  
 7.1.4 it has all necessary right, title, and interest in the
Brookhill-Wilk Patents to grant the rights, licenses, covenants not to sue or assert, and releases contained in paragraphs 3.1 and 3.4 of this Agreement; 
  
 7.1.5 Mr. Bruder has full right and authority to execute this Agreement on behalf of Brookhill-Wilk; 
  
 7.1.6 there are no licenses, liens, conveyances, mortgages,
assignments and/or other agreements that would prevent or impair the full and complete exercise by Intuitive of any or all of the rights and licenses, or the full and complete enjoyment by Intuitive of any or all of the covenants not to sue, or the
release, granted in paragraphs 3.1 and 3.4 of this Agreement; and 
  
 7.1.7 no person or entity other than Brookhill-Wilk, Wilk and WPDC has a right to enforce any of the Licensed Patents or to collect damages for past, present or future infringement of any of them except as noted for
US Patent 5,776,126. 
  
 7.2 Wilk represents and warrants that:

  
 7.2.1 he has the authority to enter into this
Agreement; 
  
 7.2.2 this Agreement is valid,
binding and enforceable in accordance with its terms; 
  
 7.2.3 he has all necessary right, title, and interest in the Wilk Patents, and the ‘126 Patent to grant the rights, licenses, covenants not to sue or assert, and releases contained in paragraphs 3.2, 3.3, and 3.4 of this Agreement;

  
 7.2.4 he has sought the advice of independent
counsel and enters into this Agreement freely, willingly, and without reservation; 
  
 7.2.5 there are no licenses, liens, conveyances, mortgages, assignments and/or other agreements that would prevent or impair the full and
complete exercise by Intuitive of any or all of the rights and licenses, or the full and complete enjoyment by Intuitive of any or all of the covenants not to sue, or the release, granted in this Agreement; and 
  
 7.2.6 no person or entity other than Brookhill-Wilk, Wilk
and WPDC has a right to enforce any of the Licensed Patents and the ‘126 Patent or to collect damages for past, present or future infringement of any of them except as noted for US Patent 5,776,126. 
  
 7.3 WPDC represents and warrants that: 
  
 7.3.1 it is a company in good standing under the laws of the
State of New York; 
  
 7.3.2 it has the authority
to enter into this Agreement; 
  
 7.3.3 this
Agreement is valid, binding and enforceable in accordance with its terms; 
  
 7.3.4 it has all necessary right, title, and interest in the Wilk Patents, and the ‘126 Patent to grant the rights, licenses, covenants not to sue or assert, and releases contained in paragraphs 3.2, 3.3, and
3.4, of this Agreement; 
  
 7.3.5 it has sought
the advice of independent counsel and enters into this Agreement freely, willingly, and without reservation; 
  

 6 

 7.3.6 Dr. Wilk has full right and authority to execute this Agreement on behalf of WPDC;

  
 7.3.7 there are no licenses, liens,
conveyances, mortgages, assignments and/or other agreements that would prevent or impair the full and complete exercise by Intuitive of any or all of the rights and licenses, or the full and complete enjoyment by Intuitive of any or all of the
covenants not to sue, or the release, granted in this Agreement; and 
  
 7.3.8 no person or entity other than Brookhill-Wilk, Wilk and WPDC has a right to enforce any of the Licensed Patents or to collect damages for past, present or future infringement of any of them except as noted for
US Patent 5,776,126. 
  
 7.4 Licensors agree to indemnify
Intuitive and pay all associated costs of defense, including attorney fees attributable to any specific claim, in the event that any such specific claim is brought by any third party against Intuitive, where the third party claims rights that
Brookhill-Wilk, WPDC, and Wilk have conveyed to Intuitive by this Agreement. 
  
 SECTION 8 
 RELATIONSHIP OF THE PARTIES 
  
 Nothing in this Agreement shall be construed to make Licensors and Intuitive
partners, joint venturers, or create a fiduciary status or relationship between them or make either Licensors or Intuitive an agent of the other; nor will any similar relationship be deemed to exist between them. Neither Licensors nor Intuitive
shall make representations contrary to the terms of this Paragraph, nor shall either become liable by reason of any representation, act, or omission of the other contrary to the provisions of this Paragraph. This agreement is not for the benefit of
any third party (except to the extent of the dismissal of the suit brought by Brookhill-Wilk against Intuitive Surgical, Inc.’s customers) and shall not be deemed to give any right or remedy to such party. 
  
 SECTION 9 
 ASSIGNABILITY 
  
 A Party may assign its rights and obligations under this Agreement only to an entity or entities that acquire(s) all or substantially all of the Party’s business or assets related to this Agreement, whether
through purchase, merger, reorganization or otherwise. In the case of such assignment, the assignee shall have the rights and obligations of the assignor under this Agreement to the same extent as if the assignee had been named as a Party to the
agreement. 
  
 SECTION 10 
 MISCELLANEOUS 
  
 10.1 Counterparts: This Agreement may be executed in counterparts, which taken together shall constitute one document. 
  
 10.2 Entire Agreement: This Agreement constitutes the entire agreement among
the Parties concerning its subject matter and supersedes all written or oral prior or contemporaneous agreements and understandings with respect to the subject matter of this Agreement. No Party shall be bound by any condition, definition,
warrantee, understanding, or representation with respect to the subject matter of this Agreement except as expressly provided in this Agreement. No variation or modification of the terms or conditions of this Agreement shall be valid unless in
writing and signed by the authorized representatives of Licensors and Intuitive. 
  
 10.3 Severability. If any provision of this Agreement is declared by a court of competent jurisdiction or by operation of law to be invalid, illegal, unenforceable, or void, then Licensors and Intuitive shall be
relieved of all obligations arising under such provision, but only to the extent that such provision is invalid, illegal, 

  

 7 

 
unenforceable, or void. If the remainder of this Agreement is capable of substantial performance, then each provision not so affected shall be enforced to
the extent permitted by law, and the invalid term or provision shall be replaced by such valid term or provision as comes closest to the intentions of the Licensors and Intuitive underlying the invalid term or provision. 
  
 10.4 Mutual Drafting. This Agreement is the joint product of the Parties and
their respective counsel, and each provision of this Agreement has been subject to the mutual consultation, negotiation and agreement of the Parties and counsel, and shall not be construed for or against any Party on the basis of authorship.

  
 10.5 No Other Agreement. Licensors and Intuitive each
represent that in entering into this Agreement, they rely on no promise, inducement, or other agreement not expressly contained in this Agreement; that they have read this Agreement and discussed it thoroughly with their respective legal counsel;
that they understand all of the provisions of this Agreement and intend to be bound by them; and that they enter into this Agreement voluntarily. 
  
 10.6 Governing Law/Venue. This Agreement is made and entered into in the State of New York and shall be construed, governed, interpreted, and enforced in
accordance with the laws of the State of New York, except that questions affecting the construction and effect of the Licensed Patents shall be determined by the law of the United States. Except as provided otherwise in this Agreement, any dispute,
claim or controversy arising out of or relating to this Agreement, or the breach, or validity of this Agreement shall be adjudicated only by a court of competent jurisdiction in the County of New York, State of New York, and all parties hereby
consent to jurisdiction and venue in such County. 
  
 10.7
Attorneys Fees. The prevailing Party shall be entitled to recover from the losing Party or Parties its reasonable attorneys’ fees and costs incurred in any lawsuit or other action with respect to any claim arising from the facts or obligations
set forth in this Agreement. 
  

 8 

 IN WITNESS WHEREOF, the duly authorized representatives of Licensors and Intuitive have executed
this Agreement. 
  

			
	 BROOKHILL-WILK 1, LLC
	    	 INTUITIVE SURGICAL, INC.

	 

	    	 

	 RONALD B. BrUDER
 CHAIRMAN
	    	 LONNIE SMITH
 CHAIRMAN

		
	 DATE: 1/8/04
	    	 DATE: 1/13/04

		
	 

 PETER J.
WILK
 PRESIDENT
	    	 
		
	 DATE: 1/8/04
	    	 
		
	 WILK PATENT DEVELOPMENT CORP.
	    	 PETER J. WILK

		
	 

	    	 

	 PETER J. WILK
 CHAIRMAN
	    	 PETER J. WILK

		
	 DATE: 1/8/04
	    	 DATE: 1/8/04

  

 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00080-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00080-of-00352.parquet"}]]